Xerafy is set to present its advanced RAIN RFID labeling solutions tailored for the pharmaceutical and healthcare industries at the CPHI South East Asia 2026. This event will be held from July 8 to 10 in Bangkok, Thailand, where the company will be featured at the AIPIA Innovation Stage.
The company will unveil its cutting-edge RFID labeling technologies aimed at enhancing pharmaceutical packaging and boosting the traceability of medical devices. These solutions are designed to improve inventory management and provide greater visibility throughout the healthcare supply chain. Among the featured products are the XSKIN Gamma, suitable for gamma-sterilized packaging, the MICRO Medical, ideal for compact medical device identification, and the Metal Skin Delta, which is designed for use with on-metal healthcare assets and metallized packaging.
In an era where pharmaceutical supply chains are growing more intricate, Xerafy’s smart RAIN RFID labels offer crucial item-level identification and facilitate real-time data capture. This capability spans across manufacturing, sterilization, warehousing, distribution, and healthcare processes, significantly enhancing product traceability, inventory accuracy, and regulatory compliance by connecting physical items with their digital records.
According to Xerafy, their RFID solutions are engineered to thrive in challenging environments where traditional barcode systems might fall short, particularly in bulk handling, dense storage, and regulated healthcare applications. Their extensive portfolio includes specialized RFID labels and tags catering not only to healthcare but also to industries such as manufacturing, logistics, aerospace, oil and gas, and data centers.
The demonstration at CPHI South East Asia 2026 will illustrate the potential of connected packaging and RFID technology to streamline pharmaceutical and medical device supply chains, ensuring more efficient operations and enhanced management of these essential sectors.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.